click below
click below
Normal Size Small Size show me how
NSC 881 EKU
APPLIES PSYCHOPHARMACOLOGY CHILD AND ADOLESCENTS WITH NEURODEVELOPMENTAL DISORDE
| Question | Answer |
|---|---|
| Pediatric Psychopharmacology | |
| Developmental considerations- | really assess height and weight due to possible growth effects from stimulant use |
| Physiological consideration | dose appropriately, child dosing is typically based on size (weight and age), always start low and increase slow to minimize side effects. |
| ADHD | Types • ADHD combined • ADHD predominately nattentive • ADHD predominately hyperactive-impulsive |
| Possible brain structures involved with symptoms of inattention, hyperactivity and impulsivity | arise from circuits in the prefrontal cortex. |
| symptom of inattention comes from | inefficient information processing in the dorsolateral prefrontal cortex. |
| symptoms of impulsivity that can be seen in other psychiatric disorders as well are | mania, aggression, and violence and they appears to involve the orbitofrontal cortex. |
| What neuro transmitters likely to involve in the symptoms of ADHD | dopamine and noradrenaline (norepinephrine) as dopamine influences behavior such as risk taking and impulsivity and norepinephrine modulates attention, arousal, and mood |
| Evaluation tools | Connor’s and Vanderbilt. The Connors is a free tool to use, Vanderbilt has a fee attached with use but may be a part of your organizations resources. |
| Treatment of ADHD | Stimulants and other (none stimulants) |
| Stimulants - MOA | -increases norepinephrine and dopamine by blocking their reuptake and facilitating their release |
| Stimulants - Prior to treatment | assess for presence of cardiac disease (history, family history, physical exam) |
| Stimulant use on individuals with hx of heart issue | Monitor ECG, if not ECG not required |
| other intervention with stimulant use | monitor BP regularly standing and sitting |
| Stimulants contraindication | Contraindicated with co-morbid glaucoma |
| Stimulants- caution | Many drug drug interactions, watch and check for these carefully |
| Stimulants- patient education | Take with food-may delay peak action for 2-3 hours, except Vyvanse. Vyvanse can be taken with or without food with no effects |
| Stimulant considerations | • Monitor height and weight • Avoid late in the day dosing due to possible insomnia • Sleep patterns-common to use melatonin to aid with sleep issues • Patients may experience weight loss • Mild side effects are common • High abuse potential, schedu |
| Drug holidays may be beneficial due | due to the effect of growth and development. |
| Sometimes these drugs can make the kids feel worse, so be sure to | asses and address that concern with the family. |
| Stimulant side effects - Methylphenidates | have the rare side effect of priapism rare but possible side effect of leukopenia and anemia |
| rare but possible side effect of leukopenia and anemia from the Stimulant Methylphenidates | require periodic monitoring of CBC, platelet counts |
| Other side effects of Stimulants | • Insomnia • Headache • Tics • Nervousness • Irritability • Overstimulation • Tremor • Dizziness • Dry mouth • GI symptoms • Nausea • Constipation • Anorexia • Weight loss |
| DHD Pharmacological Treatments Other (non stimulants) | Atomoxetine (Strattera) Buproprion (Wellbutrin IR, SR, XL) - off label ADHD wk 2 Chlorpromazine (Thorazine) - off label hyperactivity wk 4 Haloperidol (Haldol)- off label hyperactivity wk 4 Clonidine (Catapress IR) (Kapvay long acting) Guanfaci |
| Kapvay | FDA approved for ADHD ages 6-17 |
| Clonidine (Catapress IR) (Kapvay long acting) | Off label use – motor tics, Tourette syndrome, ODD, Conduct disorder, Pervasive developmental disorders |
| clonidine (Catapress IR) | Off label use for ADHD |
| Clonidine (Catapress IR) (Kapvay long acting) side effects include | Side effects include dry mouth, dizziness, constipation, sedation, fatigue |
| Guanfacine (Intuniv long acting, Tenex IR) | Used off label for ODD, conduct disorder, pervasive development disorders, motor tics, and Tourette’s syndrome |
| Guanfacine - Use in caution | with renal, hepatic, and cardiac impaired patients |
| Side effects | include dry mouth, dizziness, constipation, sedation, fatigue |